CC BY-NC-ND 4.0 · Asian J Neurosurg 2024; 19(03): 395-401
DOI: 10.1055/s-0044-1787087
Original Article

Multimodality Treatment of Trigeminal Neuralgia: An Institutional Experience

Nemi Chand Poonia
1   Department of Neurosurgery, Neuro Care Hospital & Research Centre Pvt. Ltd., Jaipur, Rajasthan, India
,
2   Department of Neurosurgery, Sawai Man Singh Medical College, Jaipur, Rajasthan, India
,
Hardika Poonia
3   Jaipur National University, Jaipur, Rajasthan, India
› Author Affiliations

Abstract

Object Trigeminal neuralgia (TN) consists of excruciating paroxysmal pain, which lasts for seconds to minutes, in the distribution of fifth cranial nerve. TN is not life-threatening, but life became miserable because of high intensity of pain. This study aimed to assess the overall success rates of different treatments, considering pain relief, recurrence rates, and potential side effects.

Material and Methods A total of 203 patients of TN treated in the period of last 10 years, that is, 2013 to 2022, were included. Medial management was in 103, radiofrequency ablation in 17, neurectomy in 9, tumor excision in 6, and microvascular decompression (MVD) was done in 68 patients. Magnetic resonance imaging brain with fast imaging employing steady-state acquisition was the basic investigation to decide the etiology of disease.

Results Preliminary findings from our institutional experience indicate that a multidisciplinary approach, combining medical, surgical, and noninvasive treatments, yielded the most favorable results in managing TN. The majority of patients achieved significant pain reduction and improved quality of life with these selected therapies. However, certain subgroups of patients exhibited a higher propensity for treatment resistance, necessitating further investigation into personalized treatment strategies.

Conclusion Our study concludes that there is no definitive treatment modality (either medical or surgical) available for patients with TN. As the etiology of TN is varied, management of TN also varied, that is, multidisciplinary approach. Every type of treatment has pros and cons but when the cause of TN is vascular compression and patient's general condition permits for surgery, in such cases MVD should be preferred over the ablative procedures.



Publication History

Article published online:
18 June 2024

© 2024. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013; 33 (09) 629-808
  • 2 Montano N, Conforti G, Di Bonaventura R, Meglio M, Fernandez E, Papacci F. Advances in diagnosis and treatment of trigeminal neuralgia. Ther Clin Risk Manag 2015; 11 (11) 289-299
  • 3 Zakrzewska JM, Linskey ME. Trigeminal neuralgia. BMJ 2014; 348 (348) g474
  • 4 Jia DZ, Li G. Bioresonance hypothesis: a new mechanism on the pathogenesis of trigeminal neuralgia. Med Hypotheses 2010; 74 (03) 505-507
  • 5 Farooq S, Shah A, Hamid R. Idiopathic trigeminal neuralgia: A study of 72 cases. Int J Appl Dent Sci 2018; 4: 282-285
  • 6 Shankland II WE. Trigeminal neuralgia: typical or atypical?. Cranio 1993; 11 (02) 108-112
  • 7 Loh HS, Ling SY, Shanmuhasuntharam P, Zain R, Yeo JF, Khoo SP. Trigeminal neuralgia. A retrospective survey of a sample of patients in Singapore and Malaysia. Aust Dent J 1998; 43 (03) 188-191
  • 8 Beydoun A. Safety and efficacy of oxcarbazepine: results of randomized, double-blind trials. Pharmacotherapy 2000; 20 (8 Pt 2): 152S-158S
  • 9 Zakrzewska JM, Chaudhry Z, Nurmikko TJ, Patton DW, Mullens LE. Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain 1997; 73 (02) 223-230
  • 10 Zhang M, Gao CX, Ma KT. et al. A meta-analysis of therapeutic efficacy and safety of gabapentin in the treatment of postherpetic neuralgia from randomized controlled trials. BioMed Res Int 2018; 2018: 7474207
  • 11 Ta PCP, Dinh HQ, Nguyen K, Lin S, Ong YL, Ariyawardana A. Efficacy of gabapentin in the treatment of trigeminal neuralgia: a systematic review of randomized controlled trials. J Investig Clin Dent 2019; 10 (04) e12448
  • 12 Wu CY, Meng FG, Xu SJ, Liu YG, Wang HW. Selective percutaneous radiofrequency thermocoagulation in the treatment of trigeminal neuralgia: report on 1860 cases. Chin Med J (Engl) 2004; 117 (03) 467-470
  • 13 Kanpolat Y, Savas A, Bekar A, Berk C. Percutaneous controlled radiofrequency trigeminal rhizotomy for the treatment of idiopathic trigeminal neuralgia: 25-year experience with 1,600 patients. Neurosurgery 2001; 48 (03) 524-532
  • 14 Agrawal SM, Kambalimath DH. Peripheral neurectomy: a minimally invasive treatment for trigeminal neuralgia. A retrospective study. J Maxillofac Oral Surg 2011; 10 (03) 195-198
  • 15 Ali FM, Prasant M, Pai D, Aher VA, Kar S, Safiya T. Peripheral neurectomies: a treatment option for trigeminal neuralgia in rural practice. J Neurosci Rural Pract 2012; 3 (02) 152-157
  • 16 Yuvaraj V, Krishnan B, Therese BA, Balaji TS. Efficacy of neurectomy of peripheral branches of the trigeminal nerve in trigeminal neuralgia: a critical review of the literature. J Maxillofac Oral Surg 2019; 18 (01) 15-22
  • 17 Zhu S, Rong Q, Chen S, Li X. Pterygopalatine fossa segment neurectomy of maxillary nerve through maxillary sinus route in treating trigeminal neuralgia. J Craniomaxillofac Surg 2013; 41 (07) 652-656
  • 18 Murali R, Rovit RL. Are peripheral neurectomies of value in the treatment of trigeminal neuralgia? An analysis of new cases and cases involving previous radiofrequency Gasserian thermocoagulation. J Neurosurg 1996; 85 (03) 435-437
  • 19 Resnick DK, Levy EI, Jannetta PJ. Microvascular decompression for pediatric onset trigeminal neuralgia. Neurosurgery 1998; 43 (04) 804-807 , discussion 807–808
  • 20 Sanchez-Mejia RO, Limbo M, Cheng JS, Camara J, Ward MM, Barbaro NM. Recurrent or refractory trigeminal neuralgia after microvascular decompression, radiofrequency ablation, or radiosurgery. Neurosurg Focus 2005; 18 (05) e12
  • 21 Sharma R, Phalak M, Katiyar V, Borkar S, Kale SS, Mahapatra AK. Microvascular decompression versus stereotactic radiosurgery as primary treatment modality for trigeminal neuralgia: a systematic review and meta-analysis of prospective comparative trials. Neurol India 2018; 66 (03) 688-694
  • 22 Liu J, Chen Z, Feng T, Jiang B, Yuan Y, Yu Y. Biomedical glue sling technique in microvascular decompression for trigeminal neuralgia caused by atherosclerotic vertebrobasilar artery: a description of operative technique and clinical outcomes. World Neurosurg 2019; 128: e74-e80
  • 23 Barker II FG, Jannetta PJ, Bissonette DJ, Larkins MV, Jho HD. The long-term outcome of microvascular decompression for trigeminal neuralgia. N Engl J Med 1996; 334 (17) 1077-1083
  • 24 Sekula Jr RF, Frederickson AM, Jannetta PJ, Quigley MR, Aziz KM, Arnone GD. Microvascular decompression for elderly patients with trigeminal neuralgia: a prospective study and systematic review with meta-analysis. J Neurosurg 2011; 114 (01) 172-179
  • 25 Tomasello F, Esposito F, Abbritti RV. et al. Microvascular decompression for trigeminal neuralgia: technical refinement for complication avoidance. World Neurosurg 2016; 94: 26-31
  • 26 Zakrzewska JM, Lopez BC, Kim SE, Coakham HB. Patient reports of satisfaction after microvascular decompression and partial sensory rhizotomy for trigeminal neuralgia. Neurosurgery 2005; 56 (06) 1304-1311 , discussion 1311–1312
  • 27 Obermann M. Treatment options in trigeminal neuralgia. Ther Adv Neurol Disord 2010; 3 (02) 107-115